Vivani Medical (VANI) director granted 36,516 options at $1.22

Rhea-AI Filing Summary

Vivani Medical, Inc. director and 10% owner Gregg Williams reported receiving a grant of non-qualified stock options for 36,516 shares of common stock at an exercise price of $1.22 per share. This compensation award was made under the company’s Non-Employee Director Compensation Policy.

The options vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, subject to Mr. Williams’ continued service through that date, and are scheduled to expire on June 23, 2036.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Williams Gregg

Role null

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy)	36,516	$1.22	$45K

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 36,516 shares (Direct, null)

Footnotes (1)

1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.

Key Figures

Options granted: 36,516 options Exercise price: $1.22 per share Underlying shares: 36,516 shares +2 more

5 metrics

Options granted 36,516 options Non-qualified stock option award to Gregg Williams

Exercise price $1.22 per share Strike price for Vivani Medical common stock

Underlying shares 36,516 shares Common stock underlying the options

Post-transaction derivative holdings 36,516 options Total options directly held after the grant

Option expiration June 23, 2036 Expiration date of the non-qualified stock options

Key Terms

Non-Qualified Stock Option, Non-Employee Director Compensation Policy, vests in total, annual meeting of stockholders

4 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

Non-Employee Director Compensation Policy financial

"Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy."

vests in total financial

"The option vests in total on the earlier of (i) the first anniversary of the grant"

annual meeting of stockholders financial

"or (ii) the next annual meeting of stockholders, subject to continued service"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 07:43 PM Accepted by SEC EDGAR 06/25/2026 - 07:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Gregg

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.22	06/24/2026		A		36,516		(1)(2)	06/23/2036	Common Stock	36,516(2)	$1.22(2)	36,516(2)	D

Explanation of Responses:

1. Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.

2. The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.

	/s/ Anthony Baldor, Attorney-in-fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Vivani Medical (VANI) director Gregg Williams report on this Form 4?

Gregg Williams reported receiving a stock option grant for 36,516 shares. The non-qualified options allow him to buy Vivani Medical common stock at $1.22 per share as part of his compensation as a non-employee director.

What are the key terms of Gregg Williams’ Vivani Medical stock option grant?

The grant covers 36,516 options at an exercise price of $1.22 per share. The options relate to an equal number of Vivani Medical common shares and were reported as directly held following the transaction.

How and when do Gregg Williams’ Vivani Medical options vest?

The options vest in full on a single future date. Vesting occurs on the earlier of the first anniversary of the grant or the next annual meeting of stockholders, provided he continues to serve as a director through that date.

When do the Vivani Medical options granted to Gregg Williams expire?

The reported non-qualified stock options expire on June 23, 2036. After that expiration date, any unexercised options will no longer be exercisable, limiting the time period during which he may purchase shares at $1.22.

Is Gregg Williams’ Vivani Medical stock option grant a market purchase or sale?

The transaction is a compensation-related grant, not a market trade. It is reported with code A as a grant or award acquisition under the Non-Employee Director Compensation Policy, meaning no open-market buying or selling occurred in this filing.